Literature DB >> 11224934

Concerns of pregnant women about bing tested for HIV: a study in a predominately Mexican-American population.

E O Parra1, T I Doran, L M Ivy, J M Aranda, C Hernandez.   

Abstract

More than 90% of pediatric acquired immune deficiency syndrome (AIDS) cases are due to mother-to-child (vertical) transmission. Medical intervention can reduce the risk of vertical transmission human immunodeficiency virus (HIV) from 25% to less than 8%. However, studies have suggested that approximately one-fourth of women may refuse HIV testing as part of routine prenatal care. The purpose of this study was to identify concerns that pregnant women might have that would impact their decision to undergo HIV testing in pregnancy. The study is a cross-sectional survey of 413 pregnant women in south Texas. A survey questionnaire was used to assess reasons why subjects might avoid HIV testing and to assess their risks for HIV infection. The reasons for not wanting HIV testing grouped around four themes: (1) fear of being stigmatized as sexually promiscuous or as an injecting drug user; (2) denial about the possibility of being infected; (3) fatalism; and (4) of rejection leading to loss of emotional and financial support. Overall, 15% of subjects who had not been previously tested (5% of all subjects) indicated that they would refuse HIV testing, a rate which is below rates of 20%-24% in previous studies. The lower rate of refusal for HIV testing in our study may reflect a downward trend nationally in the rate of refusal for prenatal testing. Many women have concerns about HIV testing, although these concerns may not necessarily prevent them from undergoing testing. Physicians and policy makers need to be aware of women's concerns and fears when implementing HIV testing policies.

Entities:  

Mesh:

Year:  2001        PMID: 11224934     DOI: 10.1089/108729101300003681

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  8 in total

Review 1.  The utilization of testing and counseling for HIV: a review of the social and behavioral evidence.

Authors:  Carla Makhlouf Obermeyer; Michelle Osborn
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

2.  Commentary: fatalismo reconsidered: a cautionary note for health-related research and practice with Latino populations.

Authors:  Ana E Abraído-Lanza; Anahí Viladrich; Karen R Flórez; Amarilis Céspedes; Alejandra N Aguirre; Ana Alicia De La Cruz
Journal:  Ethn Dis       Date:  2007       Impact factor: 1.847

3.  Eliminating Perinatal HIV Transmission in the United States: The Impact of Stigma.

Authors:  Kavita Shah Arora; Barbara Wilkinson
Journal:  Matern Child Health J       Date:  2017-03

Review 4.  A Critical Review and Commentary on the Challenges in Engaging HIV-Infected Latinos in the Continuum of HIV Care.

Authors:  Julie H Levison; Julia K Levinson; Margarita Alegría
Journal:  AIDS Behav       Date:  2018-08

5.  Pregnancy and HIV infection in young women in North Carolina.

Authors:  Elizabeth A Torrone; Janell Wright; Peter A Leone; Lisa B Hightow-Weidman
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

6.  The impact of acculturation on utilization of HIV prevention services and access to care among an at-risk Hispanic population.

Authors:  Janni J Kinsler; Sung-Jae Lee; Jennifer N Sayles; Peter A Newman; Allison Diamant; William Cunningham
Journal:  J Health Care Poor Underserved       Date:  2009-11

7.  "Where It Falls Apart": Barriers to Retention in HIV Care in Latino Immigrants and Migrants.

Authors:  Julie H Levison; Laura M Bogart; Iman F Khan; Dianna Mejia; Hortensia Amaro; Margarita Alegría; Steven Safren
Journal:  AIDS Patient Care STDS       Date:  2017-09       Impact factor: 5.078

8.  Barriers to the implementation of programs for the prevention of mother-to-child transmission of HIV: a cross-sectional survey in rural and urban Uganda.

Authors:  Francis Bajunirwe; Michael Muzoora
Journal:  AIDS Res Ther       Date:  2005-10-28       Impact factor: 2.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.